Prevention of preeclampsia

Journal of Clinical Investigation

Volumn 126, Issue 12, 2016, Pages 4396-4398

  Grotegut, Chad A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D;

DIABETES MELLITUS; GENE EXPRESSION; HUMAN; HYPERTENSION; MATERNAL AGE; NULLIPARA; OBESITY; PREECLAMPSIA; PRIORITY JOURNAL; REVIEW; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; BLOOD; DOUBLE BLIND PROCEDURE; FEMALE; PRE-ECLAMPSIA; PREGNANCY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

DOUBLE-BLIND METHOD; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMIN D;

EID: 85002901553     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI91300     Document Type: Review

References (25)

1. HCUP Statistical Briefs Chronological. Health-care Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality, Rockville, Maryland USA. HCUP Web site. www. hcup-us.ahrq.gov/reports/statbriefs/statbriefs. jsp. Accessed October 19, 2016.
2. American College of Obstetricians Gynecologists Task Force on Hypertension Pregnancy. Hypertension In Pregnancy. Washington, DC, USA: ACOG; 2013.
3. Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta. 2009;30(Suppl A):S32-S37.
4. Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol. 2002;2(9):656-663.
5. Levine RJ, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672-683.
6. North RA, et al. Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort. BMJ. 2011;342:d1875.
7. American Academy of Pediatrics American College of Obstetricians Gynecologists. Guidelines For Prenatal Care. 7th ed. Washington, DC, USA: AAP, ACOG; 2012.
8. LeFevre ML, US Preventive Services Task Force. Low-dose aspirin use for the prevention of morbidity and mortality from preeclamp-sia: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;161(11):819-826.
9. Askie LM, Duley L, Henderson-Smart DJ, Stewart LA, PARIS Collaborative Group. Antiplate-let agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet. 2007;369(9575):1791-1798.
10. Costantine MM, Cleary K, Eunice Kennedy Shriver National Institute of Child Health Human Development Obstetric-Fetal Pharmacology Research Units Network. Pravastatin for the prevention of preeclampsia in high-risk pregnant women. Obstet Gynecol. 2013;121(2 pt 1):349-353.
11. Bodnar LM, Catov JM, Simhan HN, Holick MF, Powers RW, Roberts JM. Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab. 2007;92(9):3517-3522.
12. Robinson CJ, Alanis MC, Wagner CL, Hollis BW, Johnson DD. Plasma 25-hydroxyvitamin D levels in early-onset severe preeclampsia. Am J Obstet Gynecol. 2010;203(4):366.e1-366.e6.
13. Shand AW, Nassar N, Von Dadelszen P, Innis SM, Green TJ. Maternal vitamin D status in pregnancy and adverse pregnancy outcomes in a group at high risk for pre-eclampsia. BJOG. 2010;117(13):1593-1598.
14. Xu L, Lee M, Jeyabalan A, Roberts JM. The relationship of hypovitaminosis D and IL-6 in preeclampsia. Am J Obstet Gynecol. 2014;210(2):149.e1-149.e7.
15. Pérez-López FR, et al. Effect of vitamin D supplementation during pregnancy on maternal and neonatal outcomes: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril. 2015;103(5):1278-1288.
16. De-Regil LM, Palacios C, Lombardo LK, Peña-Rosas JP. Vitamin D supplementation for women during pregnancy. Cochrane Database Syst Rev. 2016;(1):CD008873.
17. Tabesh M, Salehi-Abargouei A, Tabesh M, Esmaillzadeh A. Maternal vitamin D status and risk of pre-eclampsia: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2013;98(8):3165-3173.
18. Haugen M, et al. Vitamin D supplementation and reduced risk of preeclampsia in nulliparous women. Epidemiology. 2009;20(5):720-726.
19. Hollis BW, Wagner CL. Vitamin D and pregnan-cy: skeletal effects, nonskeletal effects, and birth outcomes. Calcif Tissue Int. 2013;92(2):128-139.
20. Mirzakhani H, et al. Early pregnancy vitamin D status and risk of preeclampsia. J Clin Invest. 2016;126(12):4702-4715.
21. Litonjua AA, et al. Effect of prenatal supplementation with vitamin D on asthma or recurrent wheezing in offspring by age 3 years: The VDAART Randomized Clinical Trial. JAMA. 2016;315(4):362-370.
22. Fischer D, et al. Metabolism of vitamin D3 in the placental tissue of normal and preeclampsia complicated pregnancies and premature births. Clin Exp Obstet Gynecol. 2007;34(2):80-84.
23. Makris A, Xu B, Yu B, Thornton C, Hennessy A. Placental deficiency of interleukin-10 (IL-10) in preeclampsia and its relationship to an IL10 promoter polymorphism. Placenta. 2006; 27(4-5):445-451.
24. ACOG Committe on Obstetric Practice. ACOG Committee Opinion No. 495: Vitamin D: screening and supplementation during pregnancy. Obstet Gynecol. 2011;118(1):197-198.
25. McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of pre-eclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J. 2008;156(5):918-930.